药物经济创新指数研究主题数据集

本数据服务基于国家健康医疗大数据中心（北方）数据资源，聚焦于药物经济创新指数研究，旨在为医药产品提供全面的经济性评估、有效性评价及市场竞争分析。通过深度挖掘区域级健康医疗大数据，结合专业研究方法和评估模型，助力药企精准决策，加速产品市场增长。
数据集基本情况：依托北方中心海量健康医疗数据，涵盖医药临床应用、药物开发、市场竞争等多维度信息，数据来源权威、可靠，经过严格的数据清洗、脱敏处理，确保数据质量与安全。
本场景中涉及的健康医疗数据：个人属性数据（性别、年龄等变量）、健康状况数据（包括但不限于主诉、现病史、既往史、输血史、过敏史、预防接种史、个人史、家族史、婚姻生育史、生命体征、体格检查结果、辅助检查结果、就诊历史、检查报告、检验报告）、医疗应用数据（包括但不限于药品及诊疗服务信息、医疗服务机构信息、病案信息、手术信息）、医疗结算数据（包括但不限于住院号、医保类型、住院起始日期、住院截止日期、住院天数、住院次数、合计金额）、卫生资源数据（包括但不限于医院名称、医院等级、医院类别）等。

This data service is grounded in the data resources of the National Health and Medical Big Data Center (Northern Branch), focusing on the research of the Pharmaceutical Economic Innovation Index. It aims to provide comprehensive economic evaluation, effectiveness assessment and market competition analysis for pharmaceutical products. By conducting in-depth mining of regional health care big data and integrating professional research methodologies and evaluation models, it assists pharmaceutical enterprises in making precise strategic decisions and accelerating the market growth of their products.

Basic Overview of the Dataset: Relying on the massive health care data of the Northern Center, this dataset covers multi-dimensional information including pharmaceutical clinical applications, drug development, market competition and other aspects. The data sources are authoritative and reliable, and have undergone strict data cleansing and de-identification processing to ensure data quality and security.

Health care data involved in this scenario include: personal attribute data (variables such as gender, age, etc.); health status data (including but not limited to chief complaints, current medical history, past medical history, blood transfusion history, allergy history, vaccination history, personal history, family history, marital and reproductive history, vital signs, physical examination findings, auxiliary examination results, medical consultation history, diagnostic examination reports, laboratory test reports); medical application data (including but not limited to information on pharmaceuticals, diagnosis and treatment services, medical service institutions, medical records and surgical information); medical settlement data (including but not limited to hospitalization number, medical insurance type, hospitalization start date, hospitalization end date, length of hospital stay, number of hospitalizations, total amount); and health resource data (including but not limited to hospital name, hospital grade, hospital category) and other related contents.

搜集汇总

数据集介绍

特点

药物经济创新指数研究主题数据集是一个基于健康医疗大数据的资源，旨在为医药产品提供经济性评估和市场竞争分析。数据集涵盖多维度医药信息，经过严格处理确保数据质量与安全，适用于药物经济评价和市场研究等场景。